These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19463308)

  • 1. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
    JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
    Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE;
    Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
    Halkin A; Masud AZ; Rogers C; Hermiller J; Feldman R; Hall P; Haber RH; Cambier PA; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA; Mehran R; Stone GW
    Am Heart J; 2006 Apr; 151(4):915.e1-7. PubMed ID: 16569562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
    Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud A; Cambier P; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA;
    Circulation; 2003 Aug; 108(5):548-53. PubMed ID: 12874191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
    Popma JJ; Cox N; Hauptmann KE; Reifart N; Virmani R; Emira K; Murphy S; Gibson CM; Grube E
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):125-34. PubMed ID: 12357506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic protection devices in saphenous percutaneous intervention.
    Morís C; Lozano I; Martín M; Rondán J; Avanzas P
    EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries.
    Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C
    Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C
    J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).
    Naidu SS; Turco MA; Mauri L; Coolong A; Popma JJ; Kereiakes DJ
    Am J Cardiol; 2010 Apr; 105(8):1060-4. PubMed ID: 20381653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience.
    Lavi S; Ivanov J; Appleby CE; Seidelin PH; Mackie K; Schwartz L; Dzavík V
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1037-44. PubMed ID: 20517966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device?
    Okabe T; Lindsay J; Torguson R; Steinberg DH; Roy P; Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):799-803. PubMed ID: 19006243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device.
    Porto I; Choudhury RP; Pillay P; Burzotta F; Trani C; Niccoli G; Blackman DJ; Channon KM; Banning AP
    Int J Cardiol; 2006 Apr; 109(1):53-8. PubMed ID: 16084611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.